These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 1551265)
1. Electrophysiologic and antiarrhythmic effects of magnesium in patients with inducible ventricular tachyarrhythmia. Hilton TC; Fredman C; Holt DJ; Bjerregaard P; Ira GH; Janosik DL Clin Cardiol; 1992 Mar; 15(3):176-80. PubMed ID: 1551265 [TBL] [Abstract][Full Text] [Related]
2. Antiarrhythmic efficacy, clinical electrophysiology, and pharmacokinetics of 3-methoxy-O-desmethyl encainide (MODE) in patients with inducible ventricular tachycardia or fibrillation. Roden DM; Lee JT; Woosley RL; Echt DS Circulation; 1989 Nov; 80(5):1247-58. PubMed ID: 2805262 [TBL] [Abstract][Full Text] [Related]
3. Magnesium therapy for intractable ventricular tachyarrhythmias in normomagnesemic patients. Iseri LT; Chung P; Tobis J West J Med; 1983 Jun; 138(6):823-8. PubMed ID: 6613108 [TBL] [Abstract][Full Text] [Related]
4. Role of autonomic nervous activity in the antiarrhythmic effects of magnesium sulfate in a canine model of polymorphic ventricular tachyarrhythmia associated with prolonged QT interval. Chinushi M; Izumi D; Komura S; Ahara S; Satoh A; Furushima H; Washizuka T; Aizawa Y J Cardiovasc Pharmacol; 2006 Sep; 48(3):121-7. PubMed ID: 17031266 [TBL] [Abstract][Full Text] [Related]
5. Mexiletine for control of drug-resistant ventricular tachycardia: clinical and electrophysiologic results in 44 patients. Waspe LE; Waxman HL; Buxton AE; Josephson ME Am J Cardiol; 1983 Apr; 51(7):1175-81. PubMed ID: 6340451 [TBL] [Abstract][Full Text] [Related]
6. Quinidine for ventricular arrhythmias: value of electrophysiologic testing. DiMarco JP; Garan H; Ruskin JN Am J Cardiol; 1983 Jan; 51(1):90-5. PubMed ID: 6849270 [TBL] [Abstract][Full Text] [Related]
7. Effects of verapamil and magnesium sulfate on electrophysiologic changes during acute myocardial ischemia and following reperfusion in dogs: comparative effects of administration by intravenous and coronary sinus retroperfusion routes. Yamamoto K; Bando S Angiology; 1996 Jun; 47(6):557-68. PubMed ID: 8678330 [TBL] [Abstract][Full Text] [Related]
8. Amiodarone for control of sustained ventricular tachyarrhythmia: clinical and electrophysiologic effects in 51 patients. Waxman HL; Groh WC; Marchlinski FE; Buxton AE; Sadowski LM; Horowitz LN; Josephson ME; Kastor JA Am J Cardiol; 1982 Nov; 50(5):1066-74. PubMed ID: 6291368 [TBL] [Abstract][Full Text] [Related]
9. Prediction of successful suppression of sustained ventricular tachyarrhythmias by serial drug testing from data derived at the initial electrophysiologic study. Kuchar DL; Rottman J; Berger E; Freeman CS; Garan H; Ruskin JN J Am Coll Cardiol; 1988 Oct; 12(4):982-8. PubMed ID: 3047198 [TBL] [Abstract][Full Text] [Related]
13. Acute electrophysiologic effects of bethanidine sulfate in patients with ventricular tachycardia or fibrillation. DiMarco JP; Sellers TD; Shipe JR; Savory J; Spyker DH Am Heart J; 1984 Nov; 108(5):1244-9. PubMed ID: 6496282 [TBL] [Abstract][Full Text] [Related]
14. Electrophysiologic effects and predictors of success of combination therapy with class Ia and Ib antiarrhythmic drugs for sustained ventricular arrhythmias. Foster MT; Peters RW; Froman D; Shorofsky SR; Gold MR Am J Cardiol; 1996 Jul; 78(1):47-50. PubMed ID: 8712117 [TBL] [Abstract][Full Text] [Related]
15. Selective prolongation of QRS late potentials by sodium channel blocking antiarrhythmic drugs: relation to slowing of ventricular tachycardia. Electrophysiologic Study Versus Electrocardiographic Monitoring Trial (ESVEM) Investigators. Freedman RA; Steinberg JS J Am Coll Cardiol; 1991 Apr; 17(5):1017-25. PubMed ID: 1848871 [TBL] [Abstract][Full Text] [Related]
16. Decreases by magnesium of QT dispersion and ventricular arrhythmias in patients with acute myocardial infarction. Parikka H; Toivonen L; Naukkarinen V; Tierala I; Pohjola-Sintonen S; Heikkilä J; Nieminen MS Eur Heart J; 1999 Jan; 20(2):111-20. PubMed ID: 10099907 [TBL] [Abstract][Full Text] [Related]
17. [Programmed stimulation in patients with malignant ventricular arrhythmia. II: Individual optimization of anti-arrhythmia therapy]. Senges J; Lengfelder W; Jauernig R; Brachmann J; Rizos I; Kübler W Herz; 1984 Apr; 9(2):77-82. PubMed ID: 6714917 [TBL] [Abstract][Full Text] [Related]
18. Clinical efficacy of intravenous amiodarone in the short term treatment of recurrent sustained ventricular tachycardia and ventricular fibrillation. Schützenberger W; Leisch F; Kerschner K; Harringer W; Herbinger W Br Heart J; 1989 Nov; 62(5):367-71. PubMed ID: 2590589 [TBL] [Abstract][Full Text] [Related]
19. [Therapeutic effectiveness of intravenous magnesium sulfate in tachyarrhythmia. Apropos of 4 clinical cases]. Rabaçal C; Pereira D; Carvalho E; Afonso JS; Pereira JN; Fernandes JS Rev Port Cardiol; 1989 Dec; 8(12):849-53. PubMed ID: 2631832 [TBL] [Abstract][Full Text] [Related]
20. [Electrophysiological effects of magnesium sulfate on human conduction system]. Yamamoto H; Bando S; Nishikado A; Nishimura N; Akiyama K; Nouzu N; Mori H Kokyu To Junkan; 1989 Jan; 37(1):77-81. PubMed ID: 2734497 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]